Skip to main content

Mesenchymal Cells in Tissue Regeneration: A Revolutionary Advancement in Regenerative Medicine

Mesenchymal Cells in Regenerative Medicine

Over the past decade, mesenchymal cells have emerged as one of the most promising solutions in regenerative medicine, particularly for tendon regeneration without surgery, delivering scientifically proven results.

These cultured stem cells not only have the capacity to differentiate into various tissue types but also possess immunomodulatory properties that are essential for repairing damaged tissues and reducing inflammation. For this reason, we will explore what mesenchymal cells are, how they function in tissue regeneration, their clinical applications, as well as the challenges and future perspectives in their use.

For more than 22 years, the Institute of Tissue Regenerative Therapy (ITRT) has developed and completed 14 human clinical trials demonstrating the safety and effectiveness of cultured mesenchymal cells for regenerating tissues such as tendon, cartilage, bone, intervertebral disc, and salivary glands. These results provide strong evidence that positions the Institute as a pioneer in scientifically-based advanced cellular therapies.

What Are Mesenchymal Cells?

Mesenchymal cells are a type of adult stem cell found in various tissues throughout the body, such as bone marrow, adipose tissue, and other connective tissues. Although they do not possess the unlimited differentiation potential of embryonic stem cells, mesenchymal cells exhibit a high capability for regenerating specific tissues of the musculoskeletal system, including bone, cartilage, tendon, and intervertebral discs.

It is important to distinguish among the different types of stem cells:

  • Adult stem cells, by contrast, have a more limited potential but are safer and more viable for therapeutic applications.
  • Cultured mesenchymal cells, such as those we use at ITRT, are a specific type of adult stem cell isolated, expanded, and controlled in the laboratory to ensure their quality, quantity, and therapeutic functionality.
  • These cells can differentiate not only into osteocytes (bone cells), chondrocytes (cartilage), myocytes (muscle), or adipocytes (fat), but also possess strong immunomodulatory, anti-inflammatory, and regenerative properties. This combination of capabilities makes them a key tool in precision regenerative medicine.

Unlike other approaches that use cells in their native state or without expansion, at ITRT we apply cultured mesenchymal cells. This method ensures a sufficient number of viable, homogeneous cells with the appropriate biological profile to achieve reproducible and scientifically validated clinical outcomes.

See also: ITRT proves for the first time that tendon can be regenerated with cultured mesenchymal stem cells

YouTube player

How Do Mesenchymal Cells Act in Tissue Regeneration?

The therapeutic effect of cultured mesenchymal cells is not limited to their differentiation capacity. Their primary mechanism of action involves interaction with the cellular microenvironment of damaged tissue through a combination of direct and indirect mechanisms that stimulate natural healing and repair processes.

Due to their biological plasticity, immunomodulatory capability, and paracrine activity, cultured mesenchymal cells have become a key therapeutic tool in advanced regenerative medicine. The following are the main mechanisms through which they act:

1. Direct Tissue Repair

Mesenchymal cells can differentiate into specialized cell types depending on their surrounding environment. For example, when administered to an area of bone injury, they can form osteoblasts; in damaged joint tissues such as cartilage, they differentiate into chondrocytes.

This cellular differentiation process enables structural repair of injured tissue and represents one of the pillars of their therapeutic potential.

2. Release of Growth Factors

Cultured mesenchymal cells act as true cellular bioreactors, releasing growth factors, cytokines, and immunoregulatory proteins that stimulate tissue regeneration from within the microenvironment.

Among the most important are:

  • VEGF, which promotes angiogenesis.
  • bFGF, which stimulates cell proliferation.
  • TGF-β, which plays a key role in tissue repair and immune modulation.

This bioactive secretion enhances the activation of resident cells, reduces oxidative damage, and fosters an environment conducive to regeneration.

3. Immunomodulation and Anti-inflammatory Effect

One of the most interesting aspects of mesenchymal cells is their ability to modulate the body’s immune response. They act as regulators of inflammation, which is essential in situations where healing processes are slow or complicated by an excessive immune response.

Mesenchymal cells can inhibit the activity of T and B cells, which are responsible for autoimmune reactions. By reducing local inflammation, mesenchymal cells promote a more favourable environment for tissue repair.

4. Intercellular Communication

In addition to direct mechanisms of differentiation and factor release, mesenchymal cells exhibit paracrine effects. This means they influence other cells through biochemical signals without direct contact. Such communication is crucial for coordinating tissue regeneration and ensuring surrounding cells respond appropriately during the healing process.

YouTube player

Challenges and Future Perspectives

Although cultured mesenchymal cells represent one of the most significant advancements in regenerative medicine, their widespread clinical implementation still faces major challenges that require a rigorous, multidisciplinary approach.

  1. Standardisation of protocols: Variability in sourcing (bone marrow and adipose tissue) and in isolation and expansion processes can significantly impact therapeutic outcomes. The lack of common standards has been one of the main barriers to replicating results in clinical settings.
  2. Safety and long-term monitoring: While multiple trials have demonstrated the safety of mesenchymal cells in various applications, there is still a need to generate robust evidence assessing their medium- and long-term effects across different tissues and conditions.
  3. Regulation and Ethics: The clinical use of stem cells is subject to strict regulations in Europe and other countries, precisely to protect patients from treatments lacking quality control, scientific evidence, and clinical validation. Unfortunately, some clinics offer so-called “stem cell” therapies without approved clinical trials or authorised manufacturing processes, posing a health risk and undermining the true potential of regenerative medicine.

The ITRT Model: Evidence, Rigour, and Results

In this context, the Institute of Tissue Regenerative Therapy (ITRT) stands as an international benchmark in regenerative medicine. For over two decades, we have presented 23 clinical trials, 14 of which have been completed in humans, demonstrating the safety and efficacy of cultured mesenchymal cells in regenerating tissues such as tendon, cartilage, bone, intervertebral disc, and salivary glands. All of this has been carried out under a clinical research model grounded in scientific evidence and strict regulatory compliance.

Here are some of the main clinical milestones achieved at ITRT through the application of cultured mesenchymal cells:

  • The vast majority of patients with grade III and IV osteoarthritis experienced pain reduction.
  • Most cases with grade III osteoarthritis showed signs of structural regeneration.
  • 9 out of 10 patients with disc degeneration showed clinical improvement, and 5 of them demonstrated morphological regeneration with increased disc hydration and height.
  • The majority of pseudoarthrosis cases achieved bone union in under 6 months.
  • Most maxillary sinus cases showed bone regeneration following cellular graft application.

Cultured mesenchymal cells represent not only a promise but a clinically validated reality for specific indications. At ITRT, we are committed to developing advanced, safe, and effective cell therapies that transform the conventional approach to treating musculoskeletal injuries and degenerative conditions.

As scientific research continues to evolve, mesenchymal cells will play a key role in the future of regenerative medicine. Our commitment is to continue leading this path with the highest scientific and ethical standards.

Otros Artículos